Urs Brändli
Chief Tech/Sci/R&D Officer en DOTTIKON ES HOLDING AG .
Fortuna: 1 M $ al 31/03/2024
Perfil
Urs Brändli es Director de Procesos y Tecnologías de Dottikon Es Holding AG.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
DOTTIKON ES HOLDING AG
0.03% | 31/03/2023 | 4 050 ( 0.03% ) | 1 M $ | 31/03/2024 |
Cargos activos de Urs Brändli
Empresas | Cargo | Inicio |
---|---|---|
DOTTIKON ES HOLDING AG | Chief Tech/Sci/R&D Officer | 01/01/2003 |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Corporate Officer/Principal | - |
Dottikon Es Management AG | Corporate Officer/Principal | - |
Swiss Chemical Society
Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
DOTTIKON ES HOLDING AG | Process Industries |
Empresas privadas | 3 |
---|---|
Swiss Chemical Society
Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland. | Commercial Services |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Health Technology |
Dottikon Es Management AG |
- Bolsa de valores
- Insiders
- Urs Brändli